Literature DB >> 24559558

HPV-associated diseases.

Suzana Ljubojevic1, Mihael Skerlev2.   

Abstract

Nearly 200 distinct human papilloma viruses (HPVs) have now been recognized, and each is associated with a specific set of clinical lesions. They are associated with a spectrum of diseases, from benign verrucae vulgares and condylomata acuminata to the malignancies of the cervix, vulva, anus, and penis. Disease associated with HPV can be divided into skin and mucosal lesion of the genital and extragenital regions. The relationship between HPV and nonmelanoma skin cancer (NMSC) is important clinically, because NMSC is the most common form of malignancy among fair-skinned populations. HPVs have also been detected in skin tags, lichen sclerosus, seborrheic keratoses, actinic keratoses, epidermal cysts, psoriatic plaques, and plucked hairs, but cutaneous HPV can be found on healthy skin.
© 2014 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2014        PMID: 24559558     DOI: 10.1016/j.clindermatol.2013.08.007

Source DB:  PubMed          Journal:  Clin Dermatol        ISSN: 0738-081X            Impact factor:   3.541


  30 in total

1.  Therapeutic DNA Vaccines for Human Papillomavirus and Associated Diseases.

Authors:  Max A Cheng; Emily Farmer; Claire Huang; John Lin; Chien-Fu Hung; T-C Wu
Journal:  Hum Gene Ther       Date:  2018-03-16       Impact factor: 5.695

2.  Integration of Oncogenes via Sleeping Beauty as a Mouse Model of HPV16+ Oral Tumors and Immunologic Control.

Authors:  Yi-Hsin Lin; Ming-Chieh Yang; Ssu-Hsueh Tseng; Rosie Jiang; Andrew Yang; Emily Farmer; Shiwen Peng; Talia Henkle; Yung-Nien Chang; Chien-Fu Hung; T-C Wu
Journal:  Cancer Immunol Res       Date:  2018-01-23       Impact factor: 11.151

3.  An unusual, giant and benign condyloma acuminatum lesion on the genital area for more than a decade.

Authors:  Soheila Aminimoghaddam; Mohammad Hossein Badakhsh; Farrokh Taftachi; Forough Nejadisalami; Fatemeh Mahmoudzadeh
Journal:  Med J Islam Repub Iran       Date:  2014-07-13

4.  Human papillomavirus E6 and E7 oncoproteins affect the expression of cancer-related microRNAs: additional evidence in HPV-induced tumorigenesis.

Authors:  Maria Vincenza Chiantore; Giorgio Mangino; Marco Iuliano; Maria Simona Zangrillo; Ilaria De Lillis; Gabriele Vaccari; Rosita Accardi; Massimo Tommasino; Sandra Columba Cabezas; Maurizio Federico; Gianna Fiorucci; Giovanna Romeo
Journal:  J Cancer Res Clin Oncol       Date:  2016-06-14       Impact factor: 4.553

5.  Restricted Recruitment of NK Cells with Impaired Function Is Caused by HPV-Driven Immunosuppressive Microenvironment of Papillomas in Aggressive Juvenile-Onset Recurrent Respiratory Papillomatosis Patients.

Authors:  Wei Wang; Yue Xi; Shilan Li; Xiangjun Liu; Guixiang Wang; Hui Wang; Mengmiao Pei; Jie Zhang; Jingang Gui; Xin Ni
Journal:  J Virol       Date:  2022-09-26       Impact factor: 6.549

Review 6.  Therapeutic Application of Genome Editing Technologies in Viral Diseases.

Authors:  Tae Hyeong Kim; Seong-Wook Lee
Journal:  Int J Mol Sci       Date:  2022-05-12       Impact factor: 6.208

Review 7.  Cervical Cancer Immunotherapy: Facts and Hopes.

Authors:  Louise Ferrall; Ken Y Lin; Richard B S Roden; Chien-Fu Hung; T-C Wu
Journal:  Clin Cancer Res       Date:  2021-04-22       Impact factor: 12.531

8.  Environmental DNA monitoring of oncogenic viral shedding and genomic profiling of sea turtle fibropapillomatosis reveals unusual viral dynamics.

Authors:  Jessica A Farrell; Kelsey Yetsko; Liam Whitmore; Jenny Whilde; Catherine B Eastman; Devon Rollinson Ramia; Rachel Thomas; Paul Linser; Simon Creer; Brooke Burkhalter; Christine Schnitzler; David J Duffy
Journal:  Commun Biol       Date:  2021-05-12

Review 9.  Antiviral Activities of Human Host Defense Peptides.

Authors:  David C Brice; Gill Diamond
Journal:  Curr Med Chem       Date:  2020       Impact factor: 4.530

10.  The best protection is early detection: Fostering timely and accurate screening.

Authors:  Aila Akosua Kattner
Journal:  Biomed J       Date:  2022-01-15       Impact factor: 7.892

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.